Back to all articles Explore Our Opportunities
Mon, Sep 16, 2019

Call to participate in an EDCTP workshop: how do we address the gender and regional disparities in EDCTP funded research?

                                    

Enhancing networking among African and European scientists to close regional and gender disparities experienced in EDCTP1 and EDCTP2 funded health research capacity activities in sub-Saharan Africa

Start date:19 November 2019, 09:00

End date:20 November 2019, 17:00

Location:Africa CDC, Africa Union Headquarters, Addis Ababa, Ethiopia

Objective: To facilitate collaborations between African and European scientists geared towards closing regional and gender imbalances seen in previously and currently funded EDCTP1 and EDCTP2 projects.

Specific objectives:
1. To brainstorm on practical solutions to address the regional, sub-regional and gender research and research capacity imbalances;
2. Prioritise and discuss potential strategies and plans to address these gaps (categorized into short, medium and long term);
3. Identify potential synergies and complementarities with the efforts and plans of EDCTP strategic partners to address these gaps.

Expected outputs:
– A clearer understanding of the challenges in regional and gender imbalances that exist within health research in sub-Saharan Africa (with a focus on EDCTP funded projects)
– To identify suitable collaborative strategies that will improve both geographical and gender distribution in future funded projects (short, medium, and long term strategies)
– To align or synergise the EDCTP efforts in the intended objective with initiatives being implemented by its like-minded partners.

Eligible participants: Scientists/researchers (from sub-Saharan Africa and Europe) working in the scope of EDCTP intending to apply for future EDCTP2 grants will be eligible to attend the planned workshop including:
– Members of the EDCTP Alumni Network
– Members of the EDCTP Regional Networks of Excellence
– EDCTP grant holders (EDCTP 1 & EDCTP2)
– EDCTP public and private regional and global partners in R&D and health research capacity development
– Any other parties interested in fulfilling the EDCTP objective.

Participants in the workshop will be selected through an open, fair and transparent process. Selection of scientists to attend the workshop will be based on their ability to justify how their participation will meet the objectives mentioned above:
– Involvement in research within the scope of the EDCTP programme 40%
– Novel potential solutions to address gender and geographical gaps 60%.

Applicants from underrepresented countries in sub-Saharan Africa and females are encouraged to apply.
Countries in sub-Saharan Africa with disproportionately low uptake of EDCTP funded projects and/or low gender balance among project coordinators include but are not limited to Angola, Benin, Burundi, Chad, Congo, Central African Republic, DRC, eSwatini (Swaziland), Gabon, Guinea, Lesotho, Liberia Mauritius, Madagascar, Namibia, Niger, Sierra Leonne, Rwanda, and Togo.

http://www.edctp.org/event/call-for-participants-to-attend-workshop/

 

Articles

Tue, May 30, 2023

Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023

The Stop TB Partnership Working Group on New TB Vaccines (WGNV) and the National Institute for Allergy and Infectious Diseases (NIAID)are co-hosting a workshop on the topic of Recognition and Control of Mtb Infected Cells: From Basics to the Clinic. This workshop is intended to address the need for correlates and to identify platforms that measure recognition or control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for Research and Development of New TB Vaccines and the Strategic Framework for New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030. 

The overall goals of this workshop are to: 

  • elucidate the mechanisms by which the immune system recognizes the Mtb-infected cell 
  • explore the degree to which such recognition can lead to control of the intracellular microbe, and 
  • discuss the translational implications of these observations 

The workshop format will be largely discussion-based. Each session will have three short presentations that will provide a high-level overview of key topics within the session theme, followed by a discussion between the session chairs, speakers, and participants. 

Click here to view the programme and speakers. 

This workshop is free of charge and open to any participants interested in this topic. 

Read more
Tue, May 30, 2023

Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023

The International Society for Infectious Diseases (ISID) and the Swiss Society for Infectious Diseases (SSI) are inviting applications for their joint Infectious Diseases Research Fellowship Program. The purpose of this programme is to support infectious disease physicians and scientists from under-resourced countries through multidisciplinary clinical and laboratory training at a select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID Fellowship programme is open to applicants who are 40 years or younger, citizens and permanent residents of under-resourced countries or Eastern Europe. The deadline for applications is 16 June 2023. 

More information: https://na.eventscloud.com/eSites/748378/Homepage 

Read more
Mon, May 29, 2023

Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.

The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."  

During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.   Clinical trial stakeholders (IRB/ECs, HRPP, sites, sponsors, investigators, and others) to register for the webinar here

Read more